Details of the Drug

General Information of Drug (ID: DMP1QTS)

Drug Name

Idecabtagene vicleucel

Synonyms

Bb2121

Indication

Disease Entry	ICD 11	Status	REF
Multiple myeloma	2A83	Approved	[1]
------------------------------------------------------------------------------------

ATC Code

L01XL07: Idecabtagene vicleucel

L01XL: Antineoplastic cell and gene therapy

L01X: OTHER ANTINEOPLASTIC AGENTS

L01: ANTINEOPLASTIC AGENTS

L: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS

Drug Type

CAR T Cell Therapy

ADMET Property

Absorption Tmax: The time to maximum plasma concentration (Tmax) is 11 days [2]

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
B-cell maturation protein (TNFRSF17)	TTZ3P4W	TNR17_HUMAN	CAR-T-Cell-Therapy	[1]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services.
2	FDA Approved Drug Products: Abecma (Idecabtagene Vicleucel) Intravenous Infusion